|
 Biotechnology
News
A
Happy Pill for Some Biotechs (BusinessWeek)
Analysts predict 2003's rally will continue, with the winners changing
to include a few blue-chip names and select up-and-comers
India
emerges as new drug trial hot spot (Red Herring - registration)
Biotech entrepreneurs see Indian clinical trials – which can
cut costs by 60 percent – as the difference between success
and slow death.
$150,000
To Prevent An Ulcer Death (Forbes)
Widely-used pain medications like ibuprofen and naproxen can, in
rare cases, cause ulcers in the stomach or intestines. Drug companies
argue that these older pain medicines cause 107,000 hospitalizations
and 16,500 deaths a year. How much is preventing these deaths worth?
'
Rethinking
Alzheimer's (Forbes)
To help the 4 million Americans with Alzheimer's disease, drug giants
like Merck are looking to develop medicines that will clear away
clumps of protein debris from their brains--or that will prevent
the gunk from accumulating in the first place.
Genentech
Has Success In Its DNA (Forbes)
To say Genentech is having a good year is a bit of an understatement.
In an industry marked by failure of products still in the development
stage, Genentech stands out.
Merck
Looks To Weather Patent Storm (Forbes)
Merck's chief executive, Raymond Gilmartin, faced a roomful of analysts
and acknowledged his company's troubles. But he vowed to stay the
course, eschewing the big mergers that have become a habit for Pfizer,
Merck's largest competitor.
FDA
Takes On Drug Name Confusion (Forbes)
A n advisory committee to the U.S. Food and Drug Administration
met to discuss a serious problem: confusing names for prescription
drugs. The committee's decision, reportedly, is that more study
is needed.
Pharmas
eye overseas trials (Red Herring - registration required)
In a radical attempt to trim exorbitant R&D costs, U.S. drug
companies look overseas for patients on whom to perform clinical
drug trials.
Is
That Daylight for ImClone? (BusinessWeek)
The beleaguered drugmaker finally gets some good news with Swiss
approval of its cancer-fighting drug Erbitux.
USDA
Sued Over Drug-Growing Crops (Wired)
A coalition of environmental groups and consumer advocates have
sued the U.S. Agriculture Department in federal court to try to
halt the experimental planting of biotech crops engineered to make
medicine.
Go
to Biotechnology News Archive >
|
